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The positive results from the recent multicentre randomised clinical trials of mechanical 
thrombectomy have at long last reinvigorated the stroke community and open up new possibilities 
for protective strategies dealing with reperfusion-based injury.  With efficacy demonstrated up to 6 
hours after stroke onset and with some patients in the ESCAPE trial1 being treated beyond 6 hours, it 
raises the possibility of an extended time window in a select group of patients.  In order for this to 
be the case, there is a need for advanced imaging techniques to identify patients with viable 
ischaemic penumbra if treatment (i.e alteplase, thrombectomy and/or new protective strategies) is 
to be given, particularly outside the current time window.    
The recent study by Shen et al.,2 in the current issue of JCBFM, provides further validation of a 
promising MRI technique for identifying the ischaemic penumbra based on tissue metabolism.  This 
technique utilises inhalation of oxygen (oxygen challenge, OC) during T2* weighted MRI to exploit 
differences in deoxy/oxyhaemoglobin ratio within ischaemic core, penumbra and normal tissue.  
Within the ischaemic penumbra, where oxygen extraction fraction and therefore 
deoxy/oxyhaemoglobin ratio are elevated, the OC results in a greater T2* signal change.  Originally 
developed by Santosh and colleagues3 this technique has been evaluated in a number of pre-clinical 
stroke studies to confirm that tissue displaying an increased  T2* signal change to OC displays 
morphologically normal neurones, glucose metabolism, reduction in lactate during OC and recovery 
following reperfusion3-7.  Deuchar and colleagues further developed the technique using intravenous 
oxygen carriers to amplify the T2* signal change and remove potential confounds of 100% oxygen in 
the clinic8. 
One of the limitations of the OC technique is that large veins and venules will display an increased 
T2* signal change, similar to that observed in the ‘ischaemic penumbra’ thereby making it difficult to 
distinguish these non-specific changes.  Shen et al.,2 attempt to overcome this by investigating the 
time to peak (TTP) of the OC signal in addition to the amplitude of signal change.  They 
demonstrated that tissue at risk (i.e. penumbra) can be better stratified with a delayed TTP in 
addition to an amplified T2* signal during OC and that this tissue showed good correspondence with 
tissue at risk identified with perfusion-diffusion mismatch MRI.  In contrast, large veins and venules 
did not show a delayed TTP.  Initiation of reperfusion returned the TTP to normal and attenuated the 
OC T2* signal change (within tissue at risk). Importantly, this tissue was not incorporated into the 
infarct when followed up at 24 hours post-stroke.  
This development represents a further refinement in the OC technique for identifying tissue at risk 
following stroke.  In view of positive animal data from two independent groups, plus preliminary 
data in acute stroke patients9, the potential for successful translation looks promising.  Further 
validation of the technique, such as establishing appropriate thresholds, is required before it would 
likely be implemented as a diagnostic technique for acute ischaemic stroke management.   
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